Cargando…
The Management of Medullary Thyroid Carcinoma in the Era of Targeted Therapy
Medullary thyroid cancer (MTC) is a rare cancer comprising approximately 5% of all thyroid cancers. The majority arises sporadically but around 25% are hereditary forming part of the Multiple Endocrine Neoplasia (MEN) type 2 syndromes. The initial management is surgical, the extent of resection dete...
Autores principales: | Ng-Cheng-Hin, Brian, Newbold, Kate L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Touch Medical Media
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813459/ https://www.ncbi.nlm.nih.gov/pubmed/29632588 http://dx.doi.org/10.17925/EE.2016.12.01.39 |
Ejemplares similares
-
Medullary Carcinoma of Thyroid Due to GLP-1 Receptor Agonist
por: Vemula, Hasitha, et al.
Publicado: (2021) -
SUN-596 A Rare Case of Metastatic Medullary Thyroid Carcinoma to Pituitary Gland
por: Raja, Sobia, et al.
Publicado: (2019) -
ODP585 Occult metastatic medullary thyroid carcinoma without detectable primary tumor.
por: Chevais, Anastassia, et al.
Publicado: (2022) -
PSAT373 Metformin Decreases Serum Thyroglobulin Concentration in Non-Medullary Thyroid Carcinoma
por: Caetano, Celina, et al.
Publicado: (2022) -
ODP466 Case of Sporadic Medullary Thyroid Cancer Detected by Serum Calcitonin Measurement
por: Juneau, Andrea Kate, et al.
Publicado: (2022)